internationalization strategy accelerated: Weihai Kaibo Medical Devices Co., Ltd. to expand overseas market layout.
In the context of the continuous growth of global medical and health demand, Chinese medical device companies are accelerating the pace of "going out. As one of the leading manufacturers of medical consumables and diagnostic equipment in China, Weihai Kaibo Medical Devices Co., Ltd. (Weihai Kaibo Medical Instruments Co., Ltd.) recently announced that it will comprehensively promote its internationalization strategy and actively expand emerging markets such as Southeast Asia, the Middle East and South America. It marks that its global layout has entered an accelerated stage.
According to the company's senior management, Kebo Medical has successfully passed ISO 13485 quality management system certification and EU CE certification. A number of core products, including disposable sterile syringes, infusion sets, blood collection needles and rapid in vitro diagnostic kits, have been approved by many countries. At present, the company has established stable distribution channels in Vietnam, Malaysia, Brazil and other places, and has carried out in-depth cooperation with local medical institutions to provide customized medical solutions.
In order to further enhance its international competitiveness, Kaibo Medical has continued to increase R & D investment in recent years, with annual R & D expenditures accounting for more than 8% of revenue. The company's technical center has developed an intelligent blood collection system with independent intellectual property rights and a traceable electronic label syringe, which not only improves the safety of clinical use, but also meets the demand for high value-added products in the international market. In addition, the company also actively participates in international exhibitions, such as MEDICA in Dusseldorf, Germany, and Arab International Medical Equipment Exhibition (Arab Health), which effectively enhances the brand's global visibility.
At the production end, Kebo Medical has a modern GMP standard plant and automated production lines to ensure product quality in line with international standards. The company strictly implements the whole process quality control system from raw material procurement to finished product delivery, and has been unanimously recognized by many overseas customers. In 2023, the company's exports increased by nearly 45% year-on-year, and its products were exported to more than 30 countries and regions.
in the face of increasingly fierce international competition, the chairman of Kaibo Medical said: "our goal is not only to become an important player in the global supply chain, but also to build a high-end medical device brand with Chinese technological characteristics. In the next three years, the company will focus on the Latin American and African markets, while exploring the possibility of setting up regional service centers overseas to achieve localized service response. '
industry experts pointed out that with the in-depth advancement of the "Belt and Road" initiative and the overall improvement of China's medical device manufacturing level, the backbone of Weihai Kaibo is expected to play a more important role on the international stage. With reliable quality, competitive price and perfect service system, Kaibo medical is writing a new chapter of China's intelligent manufacturing to the world.
